Akero Therapeutics

Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.

11-50 employees
Founded 2017
$366.9M post ipo equity
Biotechnology
Public Company

Open Positions1

RemoteFull-TimeBiopharmaceuticalPosted
  • Play an active role in planning, conduct and evaluation of ongoing clinical trials to ensure successful execution
  • Serve as Medical Monitor for assigned clinical trials, conducting ongoing review of emerging medical/safety data and working closely with external CRO partners
  • Support/manage preparation of materials for trial-related clinical committees suchs as Data Monitoring Committees, Adjucation Committees, etc.
  • Contribute to planning, authoring, and critical review of documents submitted to regulatory authorities and ethics committee/IRBs as required (e.g., Protocols, CSRs, Investigator’s Brochure, DSURs, clinical briefing documents, components of BLA/MAA submissions)
  • Contribute to the strategic planning, authoring, and critical review of scientific data disclosures (e.g., slide presentations, posters and publications)
  • Develop professional relationships with external clinical opinion leaders, investigators, and consultants and stay abreast of competitive intelligence and other market/industry activities
  • Contribute to engagement with external stakeholders such as vendor thought leaders or other groups as needed including being the primary liaison with assigned individuals or groups.
  • Function as an independent member of the team and represent clinical development at internal cross-functional or external meetings
  • Other duties related to clinical development of EFX as assigned
Excel VBAGCPMicrosoft Excel+2 more

About Akero Therapeutics

Akero Therapeutics is a clinical-stage biopharmaceutical company revolutionizing the treatment of serious metabolic diseases. Our lead program, efruxifermin (EFX), targets metabolic dysfunction-associated steatohepatitis (MASH), a condition with significant unmet medical needs. We leverage cutting-edge scientific approaches to develop transformative therapies, restoring metabolic balance and halting disease progression. Our team combines diverse expertise and a collaborative spirit to achieve ambitious goals. Akero's commitment to innovation is reflected in our work on AKR-001, a long-acting FGF21 protein, building upon two decades of research. We utilize a robust technology stack, including tools like WordPress, Google Analytics, and Google Tag Manager, supporting a streamlined workflow. Our engineering culture fosters independent thinking and creative problem-solving, while we maintain high standards for quality and regulatory compliance (cGMP and GLP). We pride ourselves on a supportive and inclusive environment that enables growth and success. Akero is a rapidly growing company with a significant market presence in the NASH treatment space, backed by substantial funding and a public listing on NASDAQ. As a publicly traded company, Akero operates with transparency and integrity, making it an exciting and rewarding place to build your career. We offer competitive compensation and benefits, with many positions open for remote work. We are a dynamic, driven team with a passion for making a difference in the lives of patients. Join us to transform the future of metabolic disease treatment.

Tech Stack

cmswidgetsanalyticsmobilemapping